Lemonade Inc. - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Representative image of Lemonade (NYSE: LMND) stock tracking on a mobile trading screen as investors watch the digital insurer ahead of its April 29 earnings catalyst.

Read More

General business news

Lemonade (NYSE: LMND) has a big date coming. Is April 29 the quarter that changes the whole story?

Lemonade (NYSE: LMND) heads into April 29 earnings with improving loss ratios, Tesla-linked insurance buzz, and a divided market. Read more.

April 12, 2026

web analytics